|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM129097403 |
| 003 |
DE-627 |
| 005 |
20250204083555.0 |
| 007 |
tu |
| 008 |
231222s1954 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed25n0430.xml
|
| 035 |
|
|
|a (DE-627)NLM129097403
|
| 035 |
|
|
|a (NLM)13162625
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a BATTERMAN, R C
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Choline theophyllinate, a new xanthine drug for the effective oral treatment of congestive heart failure; a preliminary report
|
| 264 |
|
1 |
|c 1954
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 01.05.2003
|
| 500 |
|
|
|a Date Revised 01.12.2018
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a CONGESTIVE HEART FAILURE/therapy
|
| 650 |
|
4 |
|a THEOPHYLLINE/derivatives
|
| 650 |
|
7 |
|a Xanthines
|2 NLM
|
| 650 |
|
7 |
|a Xanthine
|2 NLM
|
| 650 |
|
7 |
|a 1AVZ07U9S7
|2 NLM
|
| 650 |
|
7 |
|a cholinophyllin
|2 NLM
|
| 650 |
|
7 |
|a 3K045XR58X
|2 NLM
|
| 650 |
|
7 |
|a Theophylline
|2 NLM
|
| 650 |
|
7 |
|a C137DTR5RG
|2 NLM
|
| 650 |
|
7 |
|a Choline
|2 NLM
|
| 650 |
|
7 |
|a N91BDP6H0X
|2 NLM
|
| 700 |
1 |
|
|a GROSSMAN, A J
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a BLACKMAN, A L
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a BROOKS, A M
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a SCHWIMMER, J
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t International record of medicine and general practice clinics
|d 1952
|g 167(1954), 5 vom: 03. Mai, Seite 261-2
|w (DE-627)NLM098172042
|x 0097-1650
|7 nnns
|
| 773 |
1 |
8 |
|g volume:167
|g year:1954
|g number:5
|g day:03
|g month:05
|g pages:261-2
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 167
|j 1954
|e 5
|b 03
|c 05
|h 261-2
|